PERK Monoclonal Antibody

    • Catalog No.:YM0517
    • Applications:WB;ELISA
    • Reactivity:Human
      • Target:
      • PERK
      • Fields:
      • >>Mitophagy - animal;>>Autophagy - animal;>>Protein processing in endoplasmic reticulum;>>Apoptosis;>>Non-alcoholic fatty liver disease;>>Alzheimer disease;>>Parkinson disease;>>Amyotrophic lateral sclerosis;>>Prion disease;>>Pathways of neurodegeneration - multiple diseases;>>Hepatitis C;>>Measles;>>Herpes simplex virus 1 infection;>>Lipid and atherosclerosis
      • Gene Name:
      • EIF2AK3
      • Protein Name:
      • Eukaryotic translation initiation factor 2-alpha kinase 3
      • Human Gene Id:
      • 9451
      • Human Swiss Prot No:
      • Q9NZJ5
      • Mouse Swiss Prot No:
      • Q9Z2B5
      • Immunogen:
      • Purified recombinant fragment of human PERK expressed in E. Coli.
      • Specificity:
      • PERK Monoclonal Antibody detects endogenous levels of PERK protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Monoclonal, Mouse
      • Dilution:
      • WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
      • Purification:
      • Affinity purification
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • EIF2AK3;PEK;PERK;Eukaryotic translation initiation factor 2-alpha kinase 3;PRKR-like endoplasmic reticulum kinase;Pancreatic eIF2-alpha kinase;HsPEK
      • Molecular Weight(Da):
      • 125kD
      • References:
      • 1. Autophagy. 2008 Apr 1;4(3):364-7.
        2. J Biol Chem. 2008 Jun 20;283(25):17020-9.
        3. Hum Mol Genet. 2008 Oct 15;17(20):3254-62.
      • Background:
      • The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015],
      • Function:
      • catalytic activity:ATP + a protein = ADP + a phosphoprotein.,disease:Defects in EIF2AK3 are the cause of Wolcott-Rallison syndrome (WRS) [MIM:226980]; also known as multiple epiphyseal dysplasia with early-onset diabetes mellitus. WRS is a rare autosomal recessive disorder, characterized by permanent neonatal or early infancy insulin-dependent diabetes and, at a later age, epiphyseal dysplasia, osteoporosis, growth retardation and other multisystem manifestations, such as hepatic and renal dysfunctions, mental retardation and cardiovascular abnormalities.,domain:The lumenal domain senses perturbations in protein folding in the ER, probably through reversible interaction with HSPA5/BIP.,enzyme regulation:Perturbation in protein folding in the endoplasmic reticulum (ER) promotes reversible dissociation from HSPA5/BIP and oligomerization, resulting in transautophosphorylation and kinase act
      • Subcellular Location:
      • Endoplasmic reticulum membrane; Single-pass type I membrane protein.
      • Expression:
      • Ubiquitous. A high level expression is seen in secretory tissues.
      • Products Images
      • Western Blot analysis using PERK Monoclonal Antibody against HEK293 (1) and EIF2AK3-hIgGFc transfected HEK293 (2) cell lysate.